Status:
NOT_YET_RECRUITING
To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
Lead Sponsor:
Tongji Hospital
Conditions:
Kidney Transplant Failure and Rejection
Transplantation, Kidney
Eligibility:
All Genders
Brief Summary
At present, renal biopsy is the gold standard for evaluating the pathology of renal transplants, but it is invasive and has the risk of serious complications; and the sampled tissue is only a small pa...
Detailed Description
At present, renal biopsy is the gold standard for evaluating the pathology of renal transplants, but it is invasive and has the risk of serious complications; and the sampled tissue is only a small pa...
Eligibility Criteria
Inclusion
- (1) Patients with MR examination after kidney transplantation;
- (2) Age/gender: unlimited;
- (3) Patients who voluntarily participate in clinical trials and sign written subject informed consent
Exclusion
- \- (1) Patients with pacemakers, unknown materials, metal implants, neurostimulators, claustrophobia, etc.
- (2) Patients who cannot tolerate adequate breath-holding for adequate MR examination;
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2031
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07145944
Start Date
September 1 2025
End Date
December 12 2031
Last Update
August 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.